Jingtong Granules for Cervicogenic Headache: Clinical Efficacy, Mechanisms, and Translational Potential.
Wei Wei Liu, Ming Xin, Hongqi Ge et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review evaluates the clinical efficacy and mechanisms of Jingtong Granules for treating cervicogenic headache (CEH). CEH is a prevalent condition impacting quality of life, with conventional treatments often leading to adverse effects. The review highlights the potential of Jingtong Granules as a safer alternative, though it notes that current evidence is preliminary and calls for high-quality clinical trials.
Key findings
- Cervicogenic headache (CEH) significantly affects daily life and quality of life.
- Conventional treatments for CEH have notable drawbacks, including adverse reactions and temporary relief.
- Jingtong Granule is a standardized Chinese patent medicine with potential multi-target effects.
- Current evidence on Jingtong Granule's efficacy for CEH is preliminary, necessitating further research.
Why it matters
Understanding alternative treatments like Jingtong Granules is crucial for clinicians managing CEH, especially given the limitations of conventional pharmacological therapies. This review provides insights into a potential safer option for patients.
What to keep in mind
Current evidence regarding Jingtong Granule for CEH is preliminary, and high-quality, large-scale clinical trials are needed.